Patient with Severe Moyamoya Disease Who Presents with Acute Cortical Blindness
Stroke 48:e126-e129, Sajja, A.,et al, 2017
Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007
Radiological Findings, Clinical Course, and Outcome in Asymptomatic Moaymoya Disease: Results of Multicenter Survey in Japan
Stroke 38:1430-1435, Kuroda,S.,et al, 2007
Clinical Features of Moyamoya Disease in the United States
Stroke 29:1347-1351, Chiu,D.,et al, 1998
Fibromuscular Dysplasia and Its Neurologic Manifestations
JAMA Neurol 76:217-226, Touze, E.,et al, 2019
Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019
Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection in 20 Patients
Neurol 81:821-824, Mawet, J.,et al, 2013
Solitaire Flow Restoration Device Versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): a Randomised, Parallel-Group, Non-Inferiority Trial
Lancet 380:1241-1249,1208, Saver, J.L.,et al, 2012
Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009
Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Symptomatic Intracranial Stenosis:Cerebrovascular Complications from Elective Stent Placement
Radiology 243:188-197, Jiang,W-J.,et al, 2007
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007
Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004
Redo Carotid Endarterectomy Versus Primary Carotid Endarterectomy
Stroke 32:2787-2792, AbuRahma,A.F.,et al, 2001
Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999
Headache at Stroke Onset:The Lausanne Stroke Registry
JNNP 58:490-492, Kumral,E.,et al, 1995
Intracerebral Hemorrhage Caused by Transmural Dissection of the Anterior Cerebral Artery
Stroke 24:1400-1402, Guridi,J.,et al, 1993
Caudate Hemorrhage with Moyamoya-Like Vasculopathy from Atherosclerotic Disease
Stroke 23:1360-1363, Steinke,W.,et al, 1992
Stroke in Young Adults
Stroke 21:382-386, Bevan,H.,et al, 1990
Cocaine and Stroke
Stroke 19:779-783, Levine,S.R.&Welch,K.M.A., 1988
Intracerebral Cavernous Angiomas
Neurol 38:1699-1704, Farmer,J.P.,et al, 1988
Computed Tomography & Pure Motor Hemiparesis
Neurol 29:490-495, Weisberg,L.A., 1979
Stroke Assoc. with Addiction to Heroin
JNNP 39:194, Brust,J.C.M.,et al, 1976
In Stroke, When is a Good Outcome Good Enough?
NEJM 386:1359-1361, Schwamm, L.H., 2022
Outcomes After Endovascular Thrombectomy with or without Alteplase in Routine Clinical Practice
JAMA Neurol 79:768-776, Smith, E.E.,et al, 2022
Atypical Presentation of Primary Angiitis of Central Nervous System Responsive to Rituximab
Stroke 53:e490-e494, Kesav, P.,et al, 2022
Thrombolysis for Acute Ischemic Stroke in the Unwitnessed or Extended Therapeutic Time Window
Neurol 94:e1241-e1248, Tsivgoulis, G.,et al, 2020
Impact of Microbleeds on Outcome Following Recanalization in Patients with Acute Ischemic Stroke
Stroke 50:127-134, Choi, K.H.,et al, 2019
Clinical Characteristics and Outcomes of Methamphetamine-Associated Intracerebral Hemorrhage
Neurol 93:e1-e7, Swor, D.E.,et al, 2019
Reversible Cerebral Vasoconstriction Syndrome
Stroke 50:2253-2258, Burton, T.M. & Bushnell, C.D., 2019
Intracranial Dural Arteriovenous Fistulae
Stroke 48:1424-1431, Reynolds, M.R.,et al, 2017
Primary Angiitis of the Central Nervous System
Stroke 48:1248-1255, Boulouis, G.,et al, 2017
Arteriovenous Malformations of the Brain
NEJM 376:1859-1866, Solomon, R.A. & Connolly, E.S., 2017
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 48:2031-2033, Tsivgoulis, G. & Safouris, A., 2017
Imaging Characteristics of Venous Parenchymal Abnormalities
Stroke 48:3258-3265, Arnoux, A.,et al, 2017
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 47:1127-1130, Purrucker, J.C.,et al, 2016
Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome
Stroke 47:1742-1747, Topcuoglu, M.A.,et al, 2016
Investigating Intracerebral Haemorrhage
BMJ 350:h2484, Wilson, D.,et al, 2015
Hemorrhagic Stroke Following Use of the Synthetic Marijuana "Spice"
Neurol 85:1177-1179, Rose, D.Z.,et al, 2015
Acute Headache Diagnosis in Pregnant Women
Neurol 85:1024-1030, Robbins, M.S.,et al, 2015
Moyamoya Disease Presenting with Subarachnoid Hemorrhage: Clinical Features and Neuroimaging of a Case Series
Brit J Neurosurg 29:804-810, Wan, M.,et al, 2015
Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis
Medicine 93:42-52, Gonzalez, I.,et al, 2014
Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome
JAMA Neurol 71:68-73, Katz, B.S.,et al, 2014
Neuroimaging in Intracerebral Hemorrhage
Stroke 45:903-908, Macellari, F.,et al, 2014
Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
Variable Presentations of Postpartum Angiopathy
Stroke 43:670-676, Fugate,J.E.,et al, 2012
Interventional Stroke Therapies in the Elderly: Are We Helping?
AJNR 33:638-642, Zeevi,N.,et al, 2012